GINS2 and neoplasm: Previous reports suggested that the subtype derived from stromal contents is a strong indicator of tumor aggressiveness and poor prognosis (Isella et al., 2017; Isella et al., 2015), which was consistent with the inherent characteristics of stromal-derived GINS2 subtype.